Fatigue is one of the most common and debilitating symptoms of multiple sclerosis (MS); it affects up to 75% of MS patients and contributes to a poorer quality of life, limited social participation, and impaired occupational functioning. In relapsing-remitting multiple sclerosis (RRMS), fatigue is a major factor in patients’ burden and reduced health-related quality of life (HRQoL).
Autoren
- Aneta Dehn
Publikation
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- CKD and High Blood Pressure
Keeping an Eye on Bidirectional Interactions
- Molecular Classification, FIGO 2023, and Chemoimmunotherapy
Endometrial carcinoma
- Psoriatic Arthritis
Older patients at risk for tachyarrhythmias
- Genetic Kidney Disease: DOUBLE PROTECT Alport
The SGLT-2 inhibitor dapagliflozin as an add-on to RAS blockade
- Case Study: Cystic Fibrosis in Adults
Recurrent Pneumonia as a Manifestation of Cystic Fibrosis
- Long COVID/Fatigue Clinic
An Innovative Approach: Neuroplasticity and Predictive Processing
- T-cell lymphomas
Diagnostic Challenges and New Treatment Options
- Interbrain Synchrony